Patent ID: 7727955

Claim:
A method for treating colic in an infant by administering a pharmaceutical formulation containing a tachykinin antagonist in a pediatric dosage form wherein the tachykinin antagonist is an NK2 antagonist selected from the group consisting of: cyclo((Asn(β-D-2-deoxy-2-acetamido-Glc)-Asp-Trp-Phe-Dap-Leu)cyclo(2β-5β)), cyclo((Asn(β-D-galactopyranosyl)-Asp-Trp-Phe-Dap-Leu)cyclo(2β-5β)), cyclo((Asn(4-O-(α-DGlc)-β-D-Glc)-Asp-Trp-Phe-Dap-Leu)cyclo(2β-5β)), and cyclo((Dap(lactobionvl)-Asp-Trp-Phe-Dap-Leu)cyclo(2β-5β)).